In a ddY mouse model of IgA nephropathy, treatment with CpG-A but not with CpG-B resulted in increased serum level of IgA-IgG2a immune complex and its glomerular depositions, along with extension of mesangial proliferative lesion [19]. The gene discussed is CD79A; the disease is IgA glomerulonephritis.